Future of drugs-Heart Disease & Stroke_Vernakalant

Drug Name
Vernakalant
Structure
 
Drug Code
RSD1235
Synonym
Kynapid, Brinavess
(3R)-1-{(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy] cyclohexyl}pyrrolidin-3-ol
Molecular Formula
C20H31NO4
Innovator
Cardiome Pharma Corp
Merck
Condition
Prevention of post-operative atrial fibrillation in patients undergoing coronary artery bypass graft surgery.
Mechanism of Action
Blocks atrial potassium and sodium channels
Clinical Phase
Not yet approved. (Filed for Orphan Drug Designation)
Approved in Europe.

Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

Webinar on ‘OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH’